Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
«FIRMA «SILICEA» LLC
2005-12-01
|
| Colección: | Российский кардиологический журнал |
| Materias: | |
| Acceso en línea: | https://russjcardiol.elpub.ru/jour/article/view/2343 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|